| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |